Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Cybersecurity (BUG) vs Nuwellis Inc (NUWE) Price & Performance

Global X CybersecurityTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Global X Cybersecurity vs Nuwellis Inc — how do they compare? Global X Cybersecurity trades at $42.4, while Nuwellis Inc trades at $3.33 (market cap $1.17M). The key difference: Global X Cybersecurity is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

BUGNUWE
Sector
Sector/ThematicTechnology
52-Week High
$41.99$558.26
52-Week Low
$23.30$2.80
Market Cap
$1.17M
Enterprise Value
-$636.97K

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Cybersecurity

BUG trades at $39.64, up 0.69% today, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The stock faces resistance near $40 and support at $39. Recent news highlights strong cybersecurity sector tailwinds, with global spending exceeding $300 billion in 2026, though the ETF faces competition from semiconductor-focused alternatives.

Outlook remains positive given cybersecurity's essential role in AI-driven cloud expansion, but valuation premiums and sector competition pose risks. The stock's performance hinges on continued enterprise budget growth and its ability to maintain relevance against disruptive AI technologies.

Nuwellis Inc

NUWE trades at $2.80, down 7.89% in the last session, with a bearish technical outlook from moving averages. The company reported a net loss of $17.52 million in 2025 despite $8.27 million revenue, reflecting a negative net margin of 217.22%. Recent developments include a CEO transition to Mike McCormick, a $6 million public offering in June 2026, and expansion in pediatric care installations, indicating strategic growth efforts amid financial challenges.

The outlook remains high-risk due to persistent losses and negative ROE/ROA, though low P/E and P/B ratios suggest undervaluation. Analyst sentiment is split evenly between buy and hold. Key risks include cash burn from negative operating cash flow and execution hurdles in scaling commercial adoption. Upside depends on revenue acceleration and cost management under new leadership.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global X Cybersecurity

BUG is a thematic ETF that invests in companies at the forefront of the global cybersecurity industry. It provides concentrated exposure to leaders in network security, endpoint protection, and cloud security, such as Fortinet, Akamai, and CrowdStrike.

Read more on BUG

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE